The anti-mutagenic properties of bile pigments

被引:56
作者
Bulmer, A. C. [1 ,2 ,4 ]
Riedc, K. [3 ]
Blanchfield, J. T. [2 ]
Wagnerc, K. -H. [3 ]
机构
[1] Univ Queensland, Sch Human Movement Studies, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia
[3] Univ Vienna, Dept Nutr Sci, Vienna, Austria
[4] Biopharma Pty Ltd, Brisbane, Qld, Australia
关键词
bilirubin; bilirubin ditaurate; biliverdin; mutagenicity; Salmonella;
D O I
10.1016/j.mrrev.2007.05.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bile pigments, including bilirubin and biliverdin, are endogenous compounds belonging to the porphyrin family of molecules. In the past, bile pigments and bilirubin in particular were thought of as useless by-products of heme catabolism that can be toxic if they accumulate. However, in the past 20 years, research probing the physiological relevance of bile pigments has been mounting, with evidence to suggest bile pigments possess significant antioxidant and anti-mutagenic properties. More specifically, bile pigments are potent peroxyl radical scavengers and inhibit the mutagenic effects of a number of classes of mutagens (polycyclic aromatic hydrocarbons, heterocyclic amines, oxidants). Coincidentally, persons with elevated circulating bilirubin concentrations have a reduced prevalence of cancer and cardio-vascular disease. Despite the encouraging in vitro anti-mutagenic effects of bile pigments, relatively little research has been conducted on their inhibitory capacity in bacterial and cultured cell assays of mutation, which might link the existing in vitro and in vivo observations. This is the first review to summarise the published data and it is our hope it will stimulate further research on these potentially preventative compounds. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 41
页数:14
相关论文
共 86 条
[1]   ENTEROHEPATIC CIRCULATION OF NONCONJUGATED BILIRUBIN IN RATS FED WITH HUMAN-MILK [J].
ALONSO, EM ;
WHITINGTON, PF ;
WHITINGTON, SH ;
RIVARD, WA ;
GIVEN, G .
JOURNAL OF PEDIATRICS, 1991, 118 (03) :425-430
[2]   METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].
AMES, BN ;
MCCANN, J ;
YAMASAKI, E .
MUTATION RESEARCH, 1975, 31 (06) :347-363
[3]   4-Nitroquinoline 1-oxide forms 8-hydroxydeoxyguanosine in human fibroblasts through reactive oxygen species [J].
Arima, Yaeno ;
Nishigori, Chikako ;
Takeuchi, Toru ;
Oka, Shigenori ;
Morimoto, Kanehisa ;
Utani, Atsushi ;
Miyachi, Yoshiki .
TOXICOLOGICAL SCIENCES, 2006, 91 (02) :382-392
[4]   Inhibitory effect of hemin, chlorophyllin and related pyrrole pigments on the mutagenicity of benzo[a]pyrene and its metabolites [J].
Arimoto, S ;
Kanyama, K ;
Rai, H ;
Hayatsu, H .
MUTATION RESEARCH-GENETIC TOXICOLOGY, 1995, 345 (3-4) :127-135
[5]   INHIBITORY EFFECT OF HEMIN ON THE MUTAGENIC ACTIVITIES OF CARCINOGENS [J].
ARIMOTO, S ;
NEGISHI, T ;
HAYATSU, H .
CANCER LETTERS, 1980, 11 (01) :29-33
[6]   ROLE OF HEMIN IN THE INHIBITION OF MUTAGENIC ACTIVITY OF 3-AMINO-1-METHYL-5H-PYRIDO[4,3-B]INDOLE (TRP-P-2) AND OTHER AMINOAZAARENES [J].
ARIMOTO, S ;
HAYATSU, H .
MUTATION RESEARCH, 1989, 213 (02) :217-226
[7]   INHIBITION OF THE MUTAGENICITY OF AMINO-ACID PYROLYSIS PRODUCTS BY HEMIN AND OTHER BIOLOGICAL PYRROLE PIGMENTS [J].
ARIMOTO, S ;
OHARA, Y ;
NAMBA, T ;
NEGISHI, T ;
HAYATSU, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 92 (02) :662-668
[8]   Inhibitory effect of bilirubin on complement-mediated hemolysis [J].
Arriaga, SM ;
Mottino, AD ;
Almará, AM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (2-3) :329-336
[9]   INTERACTION OF BILIRUBIN WITH HUMAN-SERUM ALBUMIN [J].
BEAVEN, GH ;
DALBIS, A ;
GRATZER, WB .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1973, 33 (03) :500-509
[10]  
BERNHARD K, 1953, Helv Physiol Pharmacol Acta, V11, pC12